Aranapakam M. Venkatesan

Author

Pearl River Community College

Also Known As

A Venkatesan, Aranapakam M Venkatesan, Aranapakam M. Venkatesan, Aranapakam Venkatesan

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Pearl River Community College Pfizer (United States)Women's Health Research Institute University of Connecticut NOAA Chemical Sciences Laboratory

About

Aranapakam M. Venkatesan is an author at Pearl River Community College specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	802
2	Biochemistry	9	9	445
3	Natural Sciences	8	8	380
4	Engineering	2	2	33
5	Health Sciences	2	2	82

Aranapakam M. Venkatesan

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound <b>26</b> (PKI-587), a Highly Efficacious Dual Inhibitor Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Efren Delos Santos, Journal of Medicinal Chemistry	2010	210
Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor Robert Mallon, Larry Feldberg, Judy Lucas, Clinical Cancer Research	2011	169
5-Fluoro-2-methyl-<i>N</i>-[4-(5<i>H</i>-pyrrolo[2,1-<i>c</i>]- [1,4]benzodiazepin-10(11<i>H</i>)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V<sub>2</sub>Receptors J. Donald Albright, Marvin F. Reich, Efren G. Delos Santos, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyExperimental PharmacologyMolecular PharmacologyMedicinal Chemistry	1998	148
Structure−Activity Relationship of 6-Methylidene Penems Bearing Tricyclic Heterocycles as Broad-Spectrum β-Lactamase Inhibitors: Crystallographic Structures Show Unexpected Binding of 1,4-Thiazepine Intermediates Aranapakam M. Venkatesan, Yansong Gu, Osvaldo dos Santos, Journal of Medicinal Chemistry	2004	79
Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402 Christoph M. Dehnhardt, Aranapakam M. Venkatesan, Efren Delos Santos, Journal of Medicinal Chemistry	2009	78
PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor Aranapakam M. Venkatesan, Zecheng Chen, Osvaldo dos Santos, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologySignal TransductionSignaling Pathway/Mammalian TargetMedicine	2010	71
2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer Zecheng Chen, Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Bioorganic & Medicinal Chemistry Letters Tumor BiologyMedicinePharmacologyPathologyColorectal Cancer	2009	69
5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of β-lactamases Aranapakam M. Venkatesan, Atul Agarwal, Takao Abé, Bioorganic & Medicinal Chemistry Medicinal ChemistryAntimicrobial Drug DiscoveryMedicineDrug DiscoveryBroad-spectrum Inhibitors	2007	66
Inhibition of Class A and Class C β-Lactamases by Penems: Crystallographic Structures of a Novel 1,4-Thiazepine Intermediate<sup>,</sup> Michiyoshi Nukaga, Takao Abé, Aranapakam M. Venkatesan, Biochemistry	2003	63
Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor Robert Mallon, Irwin Hollander, Larry Feldberg, Molecular Cancer Therapeutics	2010	59

Page 1